跳至主要内容
临床试验/IRCT20211010052719N1
IRCT20211010052719N1招募中未知

Investigation of the effects of three conservative treatment methods on temporomandibular disorders

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Chronic orofacial pain (more than three months) with or without restriction in opening the mouth.
  • Diagnosis of Temporomandibular disorder (Axis I) based on the RDC / TMD diagnostic criteria.
  • History of no previous treatment for TMD during the last month.
  • Having natural dentition

排除标准

  • Recent fracture of mandibular bone.
  • History of recent facial trauma
  • Congenital / developmental disorders of the jaw.
  • Systemic musculoskeletal disease.
  • Fibromyalgia.
  • Previous or current history of the cancer.
  • Skin lesions at the laser site.
  • Diagnosis of Temporomandibular disorder of articular origin based on the RDC / TMD diagnostic criteria.

研究者

相似试验

招募中
3 期
The effect of three types of mouthwash Colistin and Chlorhexidine, Tobramycin and Chlorhexidine and Chlorhexidine alone in the prevention of ventilator-associated pneumoniaVentilator associated pneumonia.Ventilator associated pneumoniaJ95.851
IRCT20200825048515N1Esfahan University of Medical Sciences96
招募中
不适用
The effects of oral care program on oropharyngeal complications and the Occurrence of ventilator associated pneumoniaCondition 1: ventilator associated pneumonia. Condition 2: oropharyngeal complications.Ventilator associated pneumoniaJ95.851
IRCT20191012045066N1Esfahan University of Medical Sciences66
已完成
不适用
Three different modalities of treatment for osteoarthritis knee in eastern Indian population.
CTRI/2017/08/009480nil45
进行中(未招募)
不适用
EXPLORATORY STUDY OF THE EFFECT OF THREE DIFFERENT LEVELS OF DOSES OF TAMOXIFEN (20, 40 Y 60 MG/DAY) OVER THE PLASMATIC CONCENTRATION OF THE MAIN ACTIVE TAMOXIFEN METABOLITE (ENDOXIFEN) IN PATIENTS WITH HORMONO-SENSITIVE BREAST CANCER, CARRIERS OF A CYP2D6 GENOTYPE POOR METABOLIZER”.Estudio exploratorio del efecto de tres diferentes niveles de dosis de tamoxifeno (20, 40 y 60 mg/día) sobre la concentración plasmática de su principal metabolito activo (endoxifeno) en pacientes con cáncer de mama hormonodependiente portadoras de un genotipo de CYP2D6 metabolizador lento”WOMEN WITH HORMONE-DEPENDENT RESECTED PRIMARY BREAST CANCER, WITHOUT EVIDENCE OF METASTATIC DISEASE AND CARRIERS OF A CYP2D6 GENOTYPE POOR METABOLIZER”.Cáncer de mama operado y sin diseminación metastásica (AJCC, 2002), con receptores hormonales positivos (receptor estrogénico RE y/o receptor de progesterona RP).Las pacientes deberán ser lentas metabolizadoras” de CYP2D6
EUCTR2007-002942-40-ESFundación de la Comunidad Valenciana Hospital Provincial de Castellón
尚未招募
不适用
Comparison of the effects of three different volumes and concentration a Local Anaesthesia in Ultrasound Guided Supraclavicular block
CTRI/2021/07/035024M Aruna Manaswini